• Raj K Keservani School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, 462033, India
  • Anil K Sharma Department of Pharmaceutics, Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, 110017, India.
  • Urmila Jarouliya School of Studies in Biotechnology, Jiwaji University, Gwalior (M.P.), 474011, India.
  • Amit Kumar Singh Faculty of Pharmaceutics, United Institute of Pharmacy, UCER, Allahabad, 211008, India.


In African countries Ebola virus has been responsible for several deaths. In addition to being a global health concern, the virus is also considered a potential biological threat.  Ebola viruses are incompletely understood pathogens that cause severe, often fatal, illnesses in humans and non-human primates. Ebola virus disease affects most of the human being and finally mortality rate increases in that county. Most of the countries are on alert for the ebola virus because peoples have worked within the boundaries of the affected area of Africa. Such people are not permitted to enter in the resident country without proper test at airport or other places.  In this review we have discussed ebola virus disease and  it affects the peoples worldwide.


Peer Review History:

Article received on- 3 August;    Revised on- 10 September; Accepted on- 15 October , Available online 15 November 2016

Academic Editor: Dr. DANIYAN Oluwatoyin Michaelorcid22.jpg, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com

UJPR follows the most transparent and toughest ‘Advanced OPEN peer review’ system. The identity of the authors and, reviewers will be known to each other. This transparent process will help to eradicate any possible malicious/purposeful interference by any person (publishing staff, reviewer, editor, author, etc) during peer review. As a result of this unique system, all reviewers will get their due recognition and respect, once their names are published in the papers. We expect that, by publishing peer review reports with published papers, will be helpful to many authors for drafting their article according to the specifications. Auhors will remove any error of their article and they will improve their article(s) according to the previous reports displayed with published article(s). The main purpose of it is ‘to improve the quality of a candidate manuscript’. Our reviewers check the ‘strength and weakness of a manuscript honestly’. There will increase in the perfection, and transparency.

Received file:blue_23983.gif        Reviewer's Comments:download_logo_r_29189.gif

Average Peer review marks at initial stage: 5.0/10

Average Peer review marks at publication stage: 7.5/10

Reviewer(s) detail:

Dr. Viney Chawlaorcid22.jpg, University Institute of Pharmaceutical Sciences, Baba Farid University of Health Sciences, Sadiq Road, Faridkot-Punjab 151203, drvineychawla@gmail.com

Dr. Tamer Elhabibiorcid22.jpg, Suez Canal University, Egypt, tamer_hassan@pharm.suez.edu.eg

Keywords: Ebola virus, ebola virus disease (evd), hemorrhagic fever, filoviruses


Download data is not yet available.

217 Views | 425 Downloads
How to Cite
Keservani, R., A. Sharma, U. Jarouliya, and A. Singh. “EBOLA VIRUS DISEASE AND ITS COMPLICATIONS”. Universal Journal of Pharmaceutical Research, Vol. 1, no. 1, Sept. 2016, doi:https://doi.org/10.22270/ujpr.v1i1.RW1.
Review Articles